Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Jukema

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Acta Cardiologica|September 9, 1999
Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol"J W Jukema, M L Simoons
Nederlands Tijdschrift Voor Geneeskunde|June 17, 2008
[Torcetrapib increases mortality in patients with a high risk of cardiovascular disorders]P C N Rensen, J W Jukema
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Hot line III: Inflammation in coronary disease: Munich, 30 August 2004B Hooft van Huysduynen, J W Jukema
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
CT imaging of the heartJ D Schuijf, J W Jukema, J J Bax
American Journal of Physiology. Heart and Circulatory Physiology|July 17, 2001
Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheterP Steendijk, E Staal, J W Jukema, et al.
Pharmacological Research|April 1, 1994
Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapyA J van Boven, J W Jukema, R Paoletti
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 15, 2017
Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatmentS C Bergheanu, M C Bodde, J W Jukema
International Journal of Cardiology|June 25, 2003
Secondary prevention in coronary heart disease patients with low HDL: which options do we have?A H Liem, J W Jukema, D J van Veldhuisen
Thrombosis and Haemostasis|May 9, 2001
Factor VII polymorphisms and myocardial infarction: what is special in Italians? REGRESS study group. Regression Growth Evaluation Statin StudyR J Nederhand, M P de Maat, J W Jukema, et al.
Pathologie-Biologie|May 18, 2004
Genetic predictive factors in restenosisP S Monraats, W R P Agema, J W Jukema
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Acta Cardiologica|September 9, 1999
Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol"J W Jukema, M L Simoons
Nederlands Tijdschrift Voor Geneeskunde|June 17, 2008
[Torcetrapib increases mortality in patients with a high risk of cardiovascular disorders]P C N Rensen, J W Jukema
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Hot line III: Inflammation in coronary disease: Munich, 30 August 2004B Hooft van Huysduynen, J W Jukema
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
CT imaging of the heartJ D Schuijf, J W Jukema, J J Bax
American Journal of Physiology. Heart and Circulatory Physiology|July 17, 2001
Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheterP Steendijk, E Staal, J W Jukema, et al.
Pharmacological Research|April 1, 1994
Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapyA J van Boven, J W Jukema, R Paoletti
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 15, 2017
Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatmentS C Bergheanu, M C Bodde, J W Jukema
International Journal of Cardiology|June 25, 2003
Secondary prevention in coronary heart disease patients with low HDL: which options do we have?A H Liem, J W Jukema, D J van Veldhuisen
Thrombosis and Haemostasis|May 9, 2001
Factor VII polymorphisms and myocardial infarction: what is special in Italians? REGRESS study group. Regression Growth Evaluation Statin StudyR J Nederhand, M P de Maat, J W Jukema, et al.
Pathologie-Biologie|May 18, 2004
Genetic predictive factors in restenosisP S Monraats, W R P Agema, J W Jukema
Pageof 23